UMOD and diabetic kidney disease: The pooled results, expressed as SMD with 95% CI, demonstrated a significant decrease in uromodulin levels in DKD patients compared to controls (SMD: -0.31; 95% CI -0.48 to -0.13, p < 0.0006) (Fig. 2).